Antigen-binding molecule having regulated conjugation between heavy-chain and light-chain Grant US-11851476-B2 United States of America 26 Dec 2023
Combination therapy using T cell redirection antigen binding molecule against cell having… Grant US-11660340-B2 United States of America 30 May 2023
Method for promoting efficiency of purification of Fc region-containing polypeptide Grant US-11649262-B2 United States of America 16 May 2023
Method for enhancing humoral immune response Grant US-11649293-B2 United States of America 16 May 2023
MULTISPECIFIC ANTIBODIES BINDING TO TUMOR-ASSOCIATED ANTIGENS CAUSING NO OR REDUCED NERVE… Application WO-2023280880-A1 World Intellectual Property Organisation (WIPO) 12 Jan 2023
MULTISPECIFIC ANTIBODIES WITH MONOVALENT BINDING TO TUMOR-ASSOCIATED ANTIGENS CAUSING NO… Application EP-4116330-A1 European Patent Office 11 Jan 2023
T cell-redirected antigen-binding molecule for cells having immunosuppression function Grant US-11505605-B2 United States of America 22 Nov 2022
MULTITARGETING ANTIGEN-BINDING MOLECULES FOR USE IN PROLIFERATIVE DISEASES Application WO-2021089748-A3 World Intellectual Property Organisation (WIPO) 02 Sep 2021
Cell injury inducing therapeutic drug for use in cancer therapy Grant US-11072666-B2 United States of America 27 Jul 2021
TREATMENT OF CANCER USING A CEA CD3 BISPECIFIC ANTIBODY AND A WNT SIGNALING INHIBITOR Application WO-2020208124-A1 World Intellectual Property Organisation (WIPO) 15 Oct 2020
COMBINED BISPECIFIC ANTIBODY AND IMMUNO-ONCOLOGY THERAPIES Application WO-2019224385-A3 World Intellectual Property Organisation (WIPO) 16 Jan 2020